|
PGM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.348600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.014200E-01 |
| Normal-vs-Stage2 |
3.942000E-01 |
| Normal-vs-Stage3 |
6.630400E-01 |
| Normal-vs-Stage4 |
7.275800E-01 |
| Stage1-vs-Stage2 |
7.509800E-01 |
| Stage1-vs-Stage3 |
9.432200E-01 |
| Stage1-vs-Stage4 |
9.993200E-01 |
| Stage2-vs-Stage3 |
8.633400E-01 |
| Stage2-vs-Stage4 |
8.178200E-01 |
| Stage3-vs-Stage4 |
9.662400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.142600E-01 |
| Normal-vs-AfricanAmerican |
6.149600E-01 |
| Normal-vs-Asian |
9.079400E-01 |
| Caucasian-vs-AfricanAmerican |
8.059800E-01 |
| Caucasian-vs-Asian |
8.146600E-01 |
| AfricanAmerican-vs-Asian |
7.536400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.440950E-01 |
| Normal-vs-Female |
1.440220E-01 |
| Male-vs-Female |
1.471630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.584800E-01 |
| Normal-vs-Extreme_Weight |
2.751800E-01 |
| Normal-vs-Obese |
8.993400E-01 |
| Normal-vs-Extreme_Obese |
8.956000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.122800E-01 |
| Normal_Weight-vs-Obese |
7.694200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.391200E-01 |
| Extreme_Weight-vs-Obese |
4.448400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.701400E-01 |
| Obese-vs-Extreme_Obese |
9.283000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.420400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.913600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.496800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.440000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.806200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.543200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.655600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.152800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.323600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.139000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.548400E-01 |
| Normal-VS-Type2 PRCC |
3.881400E-01 |
| Normal-VS-KIRP CIMP |
9.268000E-01 |
| Normal-VS-Unclassified PRCC |
2.212800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.039800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.735800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.189420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.542000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.093950E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.369400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.142200E-01 |
| Normal-vs-N1 |
2.003400E-01 |
| Normal-vs-N2 |
4.346800E-01 |
| N0-vs-N1 |
3.639600E-01 |
| N0-vs-N2 |
4.001400E-01 |
| N1-vs-N2 |
2.660800E-01 |
|
|
